Literature DB >> 8755515

SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers.

J D Chen1, K Umesono, R M Evans.   

Abstract

Transcriptional repression represents an important component in the regulation of cell differentiation and oncogenesis mediated by nuclear hormone receptors. Hormones act to relieve repression, thus allowing receptors to function as transcriptional activators. The transcriptional corepressor SMRT was identified as a silencing mediator for retinoid and thyroid hormone receptors. SMRT is highly related to another corepressor, N-CoR, suggesting the existence of a new family of receptor-interacting proteins. We demonstrate that SMRT is a ubiquitous nuclear protein that interacts with unliganded receptor heterodimers in mammalian cells. Furthermore, expression of the receptor-interacting domain of SMRT acts as an antirepressor, suggesting the potential importance of splicing variants as modulators of thyroid hormone and retinoic acid signaling.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755515      PMCID: PMC38786          DOI: 10.1073/pnas.93.15.7567

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  The C'-terminal interaction domain of the thyroid hormone receptor confers the ability of the DNA site to dictate positive or negative transcriptional activity.

Authors:  J M Holloway; C K Glass; S Adler; C A Nelson; M G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  Modular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site.

Authors:  A Baniahmad; C Steiner; A C Köhne; R Renkawitz
Journal:  Cell       Date:  1990-05-04       Impact factor: 41.582

3.  Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product.

Authors:  J Sap; A Muñoz; J Schmitt; H Stunnenberg; B Vennström
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

4.  Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist.

Authors:  K Damm; C C Thompson; R M Evans
Journal:  Nature       Date:  1989-06-22       Impact factor: 49.962

5.  The c-erb-A protein is a high-affinity receptor for thyroid hormone.

Authors:  J Sap; A Muñoz; K Damm; Y Goldberg; J Ghysdael; A Leutz; H Beug; B Vennström
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

Review 6.  The RXR heterodimers and orphan receptors.

Authors:  D J Mangelsdorf; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

7.  Ssn6-Tup1 is a general repressor of transcription in yeast.

Authors:  C A Keleher; M J Redd; J Schultz; M Carlson; A D Johnson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

8.  A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor.

Authors:  A Baniahmad; A C Köhne; R Renkawitz
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

9.  Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors.

Authors:  P S Danielian; R White; J A Lees; M G Parker
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

10.  A single point mutation in erbA restores the erythroid transforming potential of a mutant avian erythroblastosis virus (AEV) defective in both erbA and erbB oncogenes.

Authors:  K Damm; H Beug; T Graf; B Vennström
Journal:  EMBO J       Date:  1987-02       Impact factor: 11.598

View more
  70 in total

1.  In vivo transcription factor recruitment during thyroid hormone receptor-mediated activation.

Authors:  M K Kim; J S Lee; J H Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  Transcriptional anti-repression. Thyroid hormone receptor beta-2 recruits SMRT corepressor but interferes with subsequent assembly of a functional corepressor complex.

Authors:  Z Yang; S H Hong; M L Privalsky
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

3.  Mechanism of corepressor binding and release from nuclear hormone receptors.

Authors:  L Nagy; H Y Kao; J D Love; C Li; E Banayo; J T Gooch; V Krishna; K Chatterjee; R M Evans; J W Schwabe
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

4.  Unique forms of human and mouse nuclear receptor corepressor SMRT.

Authors:  P Ordentlich; M Downes; W Xie; A Genin; N B Spinner; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

5.  The SMRT corepressor is a target of phosphorylation by protein kinase CK2 (casein kinase II).

Authors:  Y Zhou; W Gross; S H Hong; M L Privalsky
Journal:  Mol Cell Biochem       Date:  2001-04       Impact factor: 3.396

6.  Hormone binding and co-regulator binding to the glucocorticoid receptor are allosterically coupled.

Authors:  Samuel J Pfaff; Robert J Fletterick
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

7.  SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia.

Authors:  S H Hong; G David; C W Wong; A Dejean; M L Privalsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

8.  Transcriptional repression by the SMRT-mSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB.

Authors:  C W Wong; M L Privalsky
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

9.  Nuclear translocation of MEK1 triggers a complex T cell response through the corepressor silencing mediator of retinoid and thyroid hormone receptor.

Authors:  Lei Guo; Chaoyu Chen; Qiaoling Liang; Mohammad Zunayet Karim; Magdalena M Gorska; Rafeul Alam
Journal:  J Immunol       Date:  2012-12-05       Impact factor: 5.422

Review 10.  How degrading: Cyp26s in hindbrain development.

Authors:  Richard J White; Thomas F Schilling
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.